The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product.In a unanimous ruling Thursday, the state’s ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

A Delaware judge tried to rewrite the rules of scientific evidence. The state’s highest court just reversed her, reining in ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key win in Delaware. With a Thursday ruling (PDF) from Delaware’s highest ...

A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer. More specifically, they ...

The Delaware Zantac ruling, if it survives on appeal, is arguably a bigger problem for mass tort defendants than lawsuits in California or Illinois state courts.

The case is Zantac (Ranitidine) Products Liability litigation (Civil Action No. N22C-09-101 ZAN) in Delaware Superior Court.

(Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause ...

The case is Zantac (Ranitidine) Products Liability litigation (Civil Action No. N22C-09-101 ZAN) in Delaware Superior Court.

Delaware judge lets more than 70,000 Zantac lawsuits go forward By Reuters | Updated - June 2, 2024 at 2:17 p.m. | Posted - June 1, 2024 at 3:09 p.m.